VA
BMRN icon

Vident Advisory’s BioMarin Pharmaceuticals BMRN Stock Holding History

Vident Advisory’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$368K Buy
6,506
+1,647
+34% +$96K ﹤0.01% 1401
2025
Q4 		$289K Sell
4,859
-3,844
-44% -$209K ﹤0.01% 1390
2025
Q3 		$471K Sell
8,703
-180
-2% -$10.3K ﹤0.01% 1228
2025
Q2 		$488K Buy
8,883
+2,837
+47% +$167K 0.01% 1067
2025
Q1 		$427K Buy
+6,046
New +$407K 0.01% 1118
2024
Q3 		– Sell
-2,877
Closed -$237K – 1434
2024
Q2 		$237K Buy
2,877
+160
+6% +$13.3K 0.01% 1214
2024
Q1 		$237K Buy
2,717
+14
+0.5% +$1.25K ﹤0.01% 1136
2023
Q4 		$261K Buy
2,703
+231
+9% +$20.4K 0.01% 1066
2023
Q3 		$219K Buy
+2,472
New +$220K 0.01% 1064

Other funds holding BMRN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return